Dexus
OTC:DEXSF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
D
|
Dexus
OTC:DEXSF
|
AU |
|
C
|
Cardinal Health Inc
XMUN:CLH
|
US |
|
S
|
Sasol Ltd
DUS:SAO
|
ZA |
|
P
|
Polygiene Group AB
STO:POLYG
|
SE |
|
M
|
Medtronic PLC
LSE:0Y6X
|
IE |
|
Lonza Group AG
F:LO3
|
CH |
Wall St Price Targets
DEXSF Price Targets Summary
Dexus
According to Wall Street analysts, the average 1-year price target for DEXSF is 4.9266 USD with a low forecast of 4.3327 USD and a high forecast of 5.579 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is DEXSF's stock price target?
Price Target
4.9266
USD
According to Wall Street analysts, the average 1-year price target for DEXSF is 4.9266 USD with a low forecast of 4.3327 USD and a high forecast of 5.579 USD.
What is the Revenue forecast for Dexus?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Revenue has been 1%. The projected CAGR for the next 8 years is 6%.
What is the Gross Profit forecast for Dexus?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 2%. The projected CAGR for the next 8 years is 4%.
What is the Operating Income forecast for Dexus?
Projected CAGR
12%
Over the last 13 years, the compound annual growth rate for Operating Income has been -2%. The projected CAGR for the next 8 years is 12%.
What is the Pre-Tax Income forecast for Dexus?
Projected CAGR
70%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been -3%. The projected CAGR for the next 3 years is 70%.
What is the Net Income forecast for Dexus?
Projected CAGR
24%
Over the last 13 years, the compound annual growth rate for Net Income has been -1%. The projected CAGR for the next 8 years is 24%.
